NIRx Medical Technologies Competitors

HemoSonics is breaking new ground in point-of-care viscoelastic (VET) #hemostasis testing. When time is critical, the Quantra® System offers rapid, accurate, and easy-to-understand results that enable clinicians to make more informed decisions, more quickly. This novel, cartridge-based point-of-care VET system is intended to assess the coagulation status of perioperative patients at the point of care. Follow us at @HemoSonics

We are glad to introduce to you Atco Pharma for Pharmaceutical Industries which is owned by family owned Group, Abo EL _Naga Group and Directed by Dr. Mustafa Abo EL _Naga and Eng. Mohamed Abo EL _Naga. Facing the challenge of continuous and technological changes, ATCO PHARMA plan of work is and formulate3d in our facility . ATCO PHARMA products is manufactured according to cGMP Guidelines, aiming to be one of the market leading companies in pharmaceutical field and looking to share our customers in caring for their patients. ATCO PHARMA is an Egyptian company operated by Egyptian professionals; well-trained Pharmacists, engineers, scientists, and technicians guarantee the perfection, and reliability for all the products to get customers trust and satisfaction; MISSION ATCO PHARMA is dedicated for continuous development of our team and development of new high quality product formulations to coop with the new trends toward better Human & Animal welfare and our business to cover the entire world. Dr. Mustafa Abo El-Naga & Eng. Mohamed Abo El-Naga established Abo El-Naga Trading Company In the field of distributing Veterinary medications and feed additives. 2 1990 Started distribution Abo El-Naga Trading Company worked as distributor in Egypt for Pfizer, Virbac and Memphis 3 1994 Started importing Abo El-Naga Trading Company started importing and became the sole agent for Laboratories Calier and Dex lberica 1999 Branding ATCO PHARMA Abo El-Naga Trading Company established the brand (ATCO PHARMA). Atco Pharma brands were produced through Toll manufacturing. Atco Pharma products cover Animal health market needs. Atocef Forte was the first brand produced from Atco Pharma product protofolio. 5 2007 Establishment of Production Facility Abo El-Naga Trading Company started project for holding pharmaceutical Factory for Human and animal heath care products. ATCO PHARMA for Pharmaceutical Industries 6 2011 GMP Licensing img Egyptian Ministry of Health issued Atco Pharma the license for 3 production lines following GMP requirements We are glad to introduce to you Atco Pharma for Pharmaceutical Industries which is owned by Abo El-Naga Group, to share with you the result of 30 years of hard work and extreme effort based on high skillfulness and long experience. Facing the challenge of this Century continuous scientific and technological changes, our plan of work is based upon our belief that human and animal welfare that should be appreciated and provided with premium services and treatments. That’s why we dedicated ourselves to give the ultimate care for their health problems. Based upon our belief to find the best solutions for Human and Animal Health problems by providing a premium service and treatment .That’s why we dedicated ourselves to give the ultimate care for their health problems. That's why we manufacture our Pharmaceutical products according to GMP, aiming to be one of the market leading companies in pharmaceutical field and looking to share our customers in caring for their patients. Our raw materials are imported from multinational leading manufacturers then are processed and formulated in our facility. Our products have a high quality comparable to other worldwide leading global brands. Our well trained Pharmacists, engineers, scientists, and technicians guarantee the perfection, and reliability for all the products. Our main policy is to get customer trust and satisfaction.

SpectraWAVE, located in Bedford, Mass., is a medical device company founded in 2017 to provide optical and computational insights that improve treatment and outcomes for patients with coronary artery disease. Now part of Philips, the company continues to advance innovation in intravascular imaging and physiology. For more information and complete indications for use, please visit www.spectrawave.com.